Karina N.

Vice President, Controller

Professional Overview
Karina N. is an accomplished finance executive with over 15 years of experience in the biotechnology and pharmaceutical industries. As the Vice President and Controller at Adverum Biotechnologies, Inc., she oversees all aspects of the company's accounting, financial reporting, and internal control functions. Karina is recognized for her strategic leadership, technical expertise, and ability to drive operational excellence.

Experience Summary

Current Role
In her current role as Vice President and Controller at Adverum Biotechnologies, Karina is responsible for managing the company's financial operations, including general accounting, treasury, tax, and financial reporting. She plays a crucial part in ensuring the organization's compliance with regulatory requirements and maintains robust internal control systems. Karina's leadership has been instrumental in streamlining financial processes and enhancing the company's overall financial management.

Career Progression
Prior to her current position, Karina served as the Executive Director and Corporate Controller at Intarcia Therapeutics, Inc. where she spearheaded the implementation of new accounting systems and processes to support the company's rapid growth. She has also held roles as the Vice President and Chief Accounting Officer at Intarcia Therapeutics and Director of Accounting at the same organization. Earlier in her career, Karina was the Director of Financial Reporting at PaxVax, Inc. and an Audit Senior Manager at Ernst & Young.

Academic Background
Karina holds a Bachelor of Science degree in Accounting from the University of California, Berkeley. She is a Certified Public Accountant (CPA) and maintains active memberships with the American Institute of Certified Public Accountants (AICPA) and the California Society of CPAs.

Areas of Expertise

• Financial reporting and accounting

• Internal control systems and compliance

• Treasury management and cash flow optimization

• Financial planning and analysis

• Process improvement and automation

• Strategic leadership and team management

Professional Impact
Throughout her career, Karina has demonstrated a strong commitment to driving financial excellence and operational efficiency. At Intarcia Therapeutics, she led the implementation of a new enterprise resource planning (ERP) system, which resulted in a 25% reduction in accounting cycle times and improved data transparency. Additionally, Karina's strategic guidance has been invaluable in supporting the company's growth initiatives and ensuring the integrity of its financial information.

Conclusion
With her extensive experience in the biotechnology and pharmaceutical sectors, Karina N. has established herself as a highly respected finance executive. Her technical expertise, strategic vision, and proven track record of driving operational improvements make her a valuable asset to Adverum Biotechnologies. Karina is poised to continue contributing to the company's success and playing a pivotal role in shaping its financial future.